Feline vaccination protocols: Is a consensus emerging?

Schweizer Archiv fur Tierheilkunde

Volumn 152, Issue 3, 2010, Pages 135-140

  Sparkes, A H ^a  

^a ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RABIES VACCINE;

ACTIVE IMMUNIZATION; ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; GROWTH, DEVELOPMENT AND AGING; IMMUNIZATION; IMMUNOLOGY; METHODOLOGY; VETERINARY MEDICINE;

ANIMALS; CATS; IMMUNIZATION, SECONDARY; IMMUNOTHERAPY, ACTIVE; RABIES VACCINES; VETERINARY MEDICINE;

ANIMALIA; CALICIVIRIDAE; FELIDAE; FELINE CALICIVIRUS; HERPESVIRIDAE; RABIES VIRUS;

EID: 77949780935     PISSN: 00367281     EISSN: None     Source Type: Journal    
DOI: 10.1024/0036-7281/a000032     Document Type: Article

References (17)

1. Clark N., Kushner N.N., Barrett C.B., Kensil C.R., Salsbury D., Cotter S.: Effi cacy and safety fi eld trials of a recombinant DNA vaccine against feline leukaemia virus infection. J. Am. Vet. Med. Assoc. 1991, 199: 1433-1443.
2. Coyne M.J., Burr J.H., Yule T.D., Harding M.J., Tresnan D.B., McGavin D.: Duration of immunity in cats after vaccination or naturally acquired infection. Vet. Rec. 2001, 149: 545-548.
3. Davis-Wurzler G.M.: Current vaccination strategies in puppies and kittens. Vet. Clin. Small Anim. Pract. 2006, 36: 607-640.
4. Day M.J., Horzinek M.C., Schultz R.D.: WSAVA VGG. Guidelines for the vaccination of dogs and cats. Compiled by the vaccination guidelines group (VGG) of the World Small Animal Veterinary Association (WSAVA). J. Small Anim. Pract. 2007, 48: 528-541.
5. Gaskell R.M., Dawson S., Radford A.D.: Duration of immunity (DOI)-the regulatory issues. Vet. Microbiol. 2006, 117: 80-85.
6. Gobar G.M., Kass P.H.: World Wide Web-based survey of vaccination practices, postvaccinal reactions, and vaccine site-associated sarcomas in cats. J. Am. Vet. Med. Assoc. 2002, 220: 1477-1482
7. Horzinek M.C., Addie D., Belak S., Boucraut-Baralon C., Egberink H., Frymus T., Gruffydd-Jones T., Hartmann K., Hosie M.J., Lloret A., Lutz H., Marsilio F., Grazia Pennisi M., Radford A.D., Thiry E., Truyen U.: Infectious disease prevention and management. J. Fel. Med. Surg. (special issue incorporating the ABCD guidelines). 2009, 7: 527-618.
8. Horzinek M.C., Thiry E.: Vaccines and vaccination: the principles and polemics. J. Fel. Med. Surg. 2009, 11: 530-537.
9. Lappin M.R., Andrews J., Jensen W.A.: Use of serologic tests to predict resistance to feline herpesvirus-1, feline calicivirus, and feline parvovirus infection in cats. J. Am. Vet. Med. Assoc. 2002, 219: 38-42.
10. Mouzin D.E., Lorenzen M.J., Haworth J.D., King V.L.: Duration of serological response to three viral antigens in cats. J. Am. Vet. Med. Assoc. 2004, 224: 61-66.
11. Pollock R.V.H., Haffer K.N.: Review of the first feline leukaemia virus vaccine. J. Am. Vet. Med. Assoc. 1991, 199: 1406-1409.
12. Richards J.R., Elston T.H., Ford R.B., Gaskell R.M., Hartmann K., Hurley K.F., Lappin M.R., Levy J.K., Rodan I., Scherk M., Schulz R.D., Sparkes A.H.: The 2006 American Association of Feline Practitioners Feline Vaccine Advisory Panel Report. J. Am. Vet. Med. Assoc. 2006, 229: 1405-1441.
13. Rosenthal R.C., Dworkis A.S.: Adverse reactions to Leukocell. J. Am. Anim. Hosp. Assoc. 1990a, 23: 515-518.
14. Rosenthal R.C., Dworkis A.S.: Incidence of and some factors affecting adverse reactions to subcutaneously administered Leukocell. Journal of the American Animal Hospital Association, 1990b, 26: 283-287.
15. Scott F.W., Geissinger C.M.: Duration of immunity in cats vaccinated with an inactivated feline panleukopenia, herpesviurs, and calicivirus vaccine. Feline Practice, 1997, 25:12-19.
16. Scott F.W., Geissinger C.M.: Long-term immunity in cats vaccinated with an inactivated trivalent vaccine. Am. J. Vet. Res. 1999, 60: 652-658.
17. Starr R.M.: Reaction rate in cats vaccinated with a new controlled titer feline panleukopenia-rhinotracheitis-calicivirus- Chlamydia psitacci vaccine. Cornell Vet. 1993, 83: 311-323.